Smarter. Stronger. Together: Achieving Quality HER2-Positive Breast Cancer Care by Educating Providers and Patients

In this on-demand webcast of a live symposium, expert faculty use case studies to highlight the latest safety and efficacy evidence supporting optimal management of patients with HER2-positive breast cancer.

Sara Hurvitz, MD, FACP
Program Director Aditya Bardia, MD, MPH Kristi Kay Orbaugh, MSN, NP, AOCNP Danielle Roman, PharmD, BCOP Physicians: maximum of 1.5 AMA PRA Category 1 Credits™ Registered Nurses: 1.5 Nursing contact hours Pharmacists: 1.5 contact hours (0.15 CEUs) Released: April 28, 2022 Expired: No longer available for credit

In this commentary, 2 oncologists, an oncology nurse, and a pharmacist discuss how recent data on HER2-targeted treatment are changing the therapeutic paradigm in early and metastatic breast cancer.

Aditya Bardia, MD, MPH Sara Hurvitz, MD, FACP Kristi Kay Orbaugh, MSN, NP, AOCNP Danielle Roman, PharmD, BCOP Released: May 10, 2022

Sara Tolaney, MD, MPH, reviews recent clinical trial data showing survival benefits from newer targeted agents in the setting of HER2-positive, advanced breast cancer with brain metastases.

Sara Tolaney, MD, MPH Released: January 3, 2023

Download these slides summarizing key points from a live Cancer Conversations webinar on optimizing the management of patients with HER2+ breast cancer using currently available HER2-directed therapies.

Sara Hurvitz, MD, FACP
Program Director Aditya Bardia, MD, MPH Kristi Kay Orbaugh, MSN, NP, AOCNP Danielle Roman, PharmD, BCOP Released: March 30, 2022

Use this Interactive Decision Support Tool to compare your choice of therapy for patients with HER2+ MBC with those of 5 renowned experts.

Aditya Bardia, MD, MPH Sara Hurvitz, MD, FACP Komal Jhaveri, MD Heather McArthur, MD, MPH Sara Tolaney, MD, MPH Released: November 23, 2022

Listen in as expert faculty discuss their approaches to and key studies for current management of patients with HER2-positive breast cancer, as well as potential implications of new data in clinical practice.

Erika P. Hamilton, MD Komal Jhaveri, MD Released: July 28, 2022

Download these slides summarizing key points from a recent podcast with expert discussion on key insights and the most recent data for the management of patients with HER2-positive breast cancer.

Erika P. Hamilton, MD Komal Jhaveri, MD Released: September 13, 2022